XML 25 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Loss
Beginning Balance at Dec. 31, 2014 $ 371.6 $ 64.2 $ 187.0 $ 227.0 $ (27.1) $ (79.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 52.0     52.0    
Total other comprehensive (loss) income (5.3)         (5.3)
Cash dividends declared 11.3     11.3    
Stock-based payments:            
Stock-based compensation 4.3   4.3      
Stock option exercises and other 0.7 0.1 1.1   (0.5)  
Performance share unit transactions (2.7) 0.5 (0.5)   (2.7)  
Excess tax benefit from stock-based compensation 0.5   0.5      
Stock repurchase program 10.6       10.6  
Ending Balance at Sep. 30, 2015 399.2 64.8 192.4 267.7 (40.9) (84.8)
Beginning Balance at Jun. 30, 2015           (84.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 18.8          
Total other comprehensive (loss) income (0.2)         (0.2)
Ending Balance at Sep. 30, 2015 399.2 64.8 192.4 267.7 (40.9) (84.8)
Beginning Balance at Dec. 31, 2015 405.6 64.8 195.6 274.9 (40.9) (88.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 31.2     31.2    
Total other comprehensive (loss) income 10.1         10.1
Cash dividends declared 12.8     12.8    
Stock-based payments:            
Stock-based compensation 2.9   2.9      
Stock option exercises and other 0.7 0.2 0.7   (0.2)  
Performance share unit transactions (2.4) 0.4 (0.4)   (2.4)  
Stock repurchase program 33.8       33.8  
Ending Balance at Sep. 30, 2016 401.5 65.4 198.8 293.3 (77.3) (78.7)
Beginning Balance at Jun. 30, 2016           (79.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 8.5          
Total other comprehensive (loss) income 0.4         0.4
Ending Balance at Sep. 30, 2016 $ 401.5 $ 65.4 $ 198.8 $ 293.3 $ (77.3) $ (78.7)